| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.37 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |